Abstract
Mental health disparities result from complex factors, including differential diagnoses, lack of access to standard mental health treatments, and inconsistent application of treatments when care is accessed. The COVID-19 pandemic exacerbated these disparities as marginalized groups had less access to testing and care while having higher infection rates. Community-based forms of care, such as music and mindfulness, are affordable and accessible options that can potentially address present mental health disparities. Specifically, music and mindfulness tools can be delivered virtually and are effective means for treating stress-related conditions. However, previous studies measuring the impact of music and mindfulness on stress-related conditions lack representation of people of African descent (PADs) and other marginalized communities. Among many reasons, bias and mistrust in recruitment strategies contribute to the lack of representation in these research studies. In this pilot study, we tested the feasibility of PAD recruitment in a virtual community-based music mindfulness research study and measured the impact of participation on perceived stress. Participants (14) with diagnosed anxiety were enrolled in an 8-week virtual music mindfulness program. We found a significant correlation between time engaged in our music mindfulness platform and lower perceived stress. Future work will evaluate the adoption and efficacy of these virtual strategies in communities when combined with and replacing standard interventions.
Competing Interest Statement
AZA Allsop is a co-founder of Mefreely, LLC, a company building an integrative wellness ecosystem. All other authors report no biomedical financial interests or potential conflicts of interest.
Clinical Trial
NCT06505226
Clinical Protocols
https://clinicaltrials.gov/study/NCT06505226?intr=music%20mindfulness&term=Allsop&rank=2
Funding Statement
This work was supported by IMPORT Grant, Yale Department of Psychiatry, 2R25MH071584, National Institute of Mental Health to ASA and Neuroscience Research Training Program, Yale Department of Psychiatry, 5T32MH019961, National Institute of Mental Health to ASA.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB Institution of Yale University gave ethical approval for this work This work is registered on clinicaltrials.gov: NCT06505226
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon request to the authors
